プロテインアッセイの世界市場レポート 2024年

プロテインアッセイの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には14.4%の年間複合成長率（CAGR）で49億2,000万米ドルに成長すると予想されます。予測期間で予想される成長は、臨床診断における応用の拡大、バイオマーカー発見の重視の高まり、バイオ医薬品の生産と品質管理の関連性の増大、調査プラットフォームにおける技術統合、と個別化治療のためのプロテオミクスプロファイリングの増加に起因すると考えられます。予測期間中に予想される主要動向には、創薬におけるプロテオミクスの利用の増加、高感度アッセイキットの開発、標準化とアッセイの再現性への焦点、プロテオミクスデータと他のオミクスデータの統合、プロテインアッセイの拡大が含まれます。臨床診断。

予想される医療インフラの急速な発展により、将来プロテインアッセイ市場が推進される態勢が整っています。医療インフラには、高度な機器、医師や看護師などの専門医療従事者、確立された製薬企業が含まれます。 プロテインアッセイは、腎臓や心血管疾患、がんなどのさまざまな状態の診断において重要な役割を果たします。 GDPに対する医療支出の増加によって示されるように、医療インフラの成長は、プロテインアッセイ市場の主要な推進力です。たとえば、2022年11月の経済協力開発機構（OECD）の報告書によると、OECD諸国全体の医療支出は2019年のGDPの8.8％から2020年の9.7％に増加し、2021年の暫定予測では、 OECD加盟20か国のグループの医療支出は6%増加しました。したがって、医療インフラの急速な発展は、プロテインアッセイ市場の成長に大きく貢献しています。

慢性疾患の有病率の増加も、プロテインアッセイ市場の成長を推進するもう1つの要因です。 1年以上続き、継続的な治療が必要な慢性疾患が増加しています。がんや神経変性疾患などの疾患により、プロテインアッセイの需要が高まっています。プロテインアッセイは、バイオマーカーの特定と疾患の理解に不可欠です。 2023年 1月に国立バイオテクノロジー情報センター（NCBI）が予測したように、少なくとも1つの慢性疾患を持つ50歳以上の人の数は99.5%増加し、2050年までに1億4,266万人に達すると予想されています。その結果、慢性疾患の有病率の増加はプロテインアッセイ市場の成長に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のプロテインアッセイ市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のプロテインアッセイの市場規模実績と成長、2018～2023年
• 世界のプロテインアッセイ市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のプロテインアッセイ市場、製品タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 試薬とキット
• 機器
• 世界のプロテインアッセイ市場、技術タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 吸光度ベースのプロテインアッセイ
• 比色プロテインアッセイ
• 蛍光ベースのプロテインアッセイ
• 世界のプロテインアッセイ市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 製薬産業
• バイオテクノロジー産業
• 臨床検査室
• 病院
• 学術研究機関

第7章 地域と国の分析

• 世界のプロテインアッセイ市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のプロテインアッセイ市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• プロテインアッセイ市場の競合情勢
• プロテインアッセイ市場の企業プロファイル
  • Pfizer Inc.
  • Johnson &Johnson
  • General Electric Company
  • F. Hoffmann-La Roche AG
  • AstraZeneca plc

第31章 その他の主要と革新的な企業

• Thermo Fisher Scientific Inc.
• Roche Diagnostics International AG
• Takeda Pharmaceutical Company Limited
• Danaher Corporation
• Eli Lilly and Company
• Merck KGaA
• Siemens Healthineers AG
• R&D Systems Inc.
• Lonza Group AG
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Takara Bio Inc.
• Qiagen NV
• Promega Corporation
• Abcam plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Protein assay refers to the process of determining how much or how many distinct proteins there are in a sample, depending on the case. Many clinical and research procedures include the isolation and detection of proteins. The protein assay is used to quantify the presence of a particular protein, or a variety of proteins, in a sample.

Protein assays encompass two primary product types reagents and kits, and instruments. Reagents, substances chosen for their chemical or biological action, are utilized in manufacturing, image development, or component detection. Protein assays employ various technologies, including absorbance-based, colorimetric, and fluorescence-based methods. These assays find applications in diverse industries such as pharmaceuticals, biotechnology, clinical laboratories, hospitals, and academic research institutes.

The protein assays market research report is one of a series of new reports from The Business Research Company that provides protein assays market statistics, including protein assays industry global market size, regional shares, competitors with a protein assays market share, detailed protein assays market segments, market trends and opportunities, and any further data you may need to thrive in the protein assays industry. This protein assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein assays market size has grown rapidly in recent years. It will grow from $2.53 billion in 2023 to $2.88 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The growth observed in the historic period can be attributed to several factors, including advancements in proteomic research, intensified activities in drug discovery and development, progress in biotechnology and life sciences research, a heightened prevalence of chronic diseases, and a growing adoption of personalized medicine.

The protein assays market size is expected to see rapid growth in the next few years. It will grow to $4.92 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period can be attributed to the expanding applications in clinical diagnostics, a growing emphasis on biomarker discovery, increasing relevance in biopharmaceutical production and quality control, technological integration in research platforms, and a rise in proteomic profiling for personalized therapies. Key trends expected in the forecast period include the increased use of proteomics in drug discovery, the development of high-sensitivity assay kits, a focus on standardization and assay reproducibility, the integration of proteomic data with other omics data, and the expansion of protein assays in clinical diagnostics.

The anticipated rapid development of healthcare infrastructure is poised to drive the protein assay market in the future. Healthcare infrastructure encompasses advanced equipment, specialized medical personnel such as doctors and nurses, and well-established pharmaceutical enterprises. Protein assays play a crucial role in diagnosing various conditions, including kidney and cardiovascular diseases, as well as cancers. The growth of healthcare infrastructure, as indicated by an increase in health spending as a percentage of GDP, is a key driver for the protein assay market. For instance, according to a report by the Organization for Economic Co-operation and Development (OECD) in November 2022, health spending across OECD countries rose from 8.8% of GDP in 2019 to 9.7% in 2020, and preliminary projections for 2021 suggested a 6% growth in health spending for a group of 20 OECD nations. Thus, the rapid development of healthcare infrastructure contributes significantly to the protein assay market's growth.

The increasing prevalence of chronic diseases is another factor propelling the growth of the protein assay market. Chronic diseases, characterized by lasting a year or longer and requiring continuous medical care, are on the rise. Conditions such as cancer and neurodegenerative disorders are driving the demand for protein assays, which are crucial for biomarker identification and understanding diseases. As projected by the National Center for Biotechnology Information (NCBI) in January 2023, the number of individuals aged 50 years and older with at least one chronic illness is expected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. Consequently, the increasing prevalence of chronic diseases contributes significantly to the growth of the protein assay market.

Major players in the protein assay market are directing their efforts towards the creation of innovative solutions, such as 3D spatial analysis kits. These kits, encompassing tools, software, and resources, are tailored for the examination and visualization of spatial data in three dimensions. For instance, in June 2023, Pixelgen Technologies AB, a biotechnology company based in Sweden, introduced the 'Pixelgen Single Cell Spatial Proteomics Kit.' Grounded in MPX technology, this kit has the potential to significantly enhance the understanding of cellular activity. It aims to drive advancements in scientific knowledge, expedite drug discovery and development processes, and enhance diagnostic capabilities. The initial release of the Pixelgen SCSP Kit includes 76 protein assays and 4 controls for simultaneous testing.

Leading companies in the protein assay sector are channeling their focus into the development of innovative solutions, such as high-plex proteomics platforms. These platforms, constituting proteomic technologies or systems, enable the simultaneous analysis of a high number of proteins in a single experiment. For instance, in November 2023, SomaLogic Inc., a US-based proteomics technology company, launched the 'somaScan 11K Platform.' This platform provides 11,000 total protein measurements, offering researchers a significant advantage in uncovering biomarkers and identifying potential drug targets for translational medicine. The addition of 3,500 proteins to the 11K assay is anticipated to reveal new biomarkers previously beyond measurement, potentially contributing to the development of diagnostics with heightened accuracy.

In October 2021, Abcam PLC, a UK-based provider of diagnostic and therapeutic applications, completed the acquisition of Biovision Inc. for USD 340 million. This strategic move strengthens Abcam's internal innovation and expands its scale to support cellular assays and biochemical assays markets. The acquisition grants Abcam access to BioVision's product line, capabilities, and a team of 70 experts in manufacturing and development. BioVision Inc., based in the US, is known for its diverse offerings, including assay kits, antibodies, recombinant proteins, and enzymes.

Major companies operating in the protein assays market report are Pfizer Inc., Johnson & Johnson, General Electric Company, F. Hoffmann-La Roche AG, AstraZeneca PLC, Thermo Fisher Scientific Inc., Roche Diagnostics International AG, Takeda Pharmaceutical Company Limited, Danaher Corporation, Eli Lilly and Company, Merck KGaA, Siemens Healthineers AG, R&D Systems Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Takara Bio Inc., Qiagen N.V., Promega Corporation, Abcam PLC, Cell Signaling Technology Inc., BioVision Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Novus Biologicals LLC, Abnova Corporation, Elabscience Biotechnology Co. Ltd., Geno Technology Inc., Cytoskeleton Inc., Lexicon Pharmaceuticals Inc.

North America was the largest region in the protein assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global protein assays market report during the forecast period. The regions covered in the protein assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein assay services market includes revenues earned by entities by providing different protein quantitation methods such as enzyme-linked immunosorbent assay (ELISA), western blot analysis, and more recently, mass spectrometry, among others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Assays Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on protein assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for protein assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The protein assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product Type: Reagents And Kits; Instruments
• 2) By Technology Type: Absorbance Based Protein Assays; Colorimetric Protein Assays; Fluorescence Based Protein Assays
• 3) By End User: Pharmaceutical Industry; Biotechnology Industry; Clinical Laboratories; Hospitals; Academic Research Institutes
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; General Electric Company; F. Hoffmann-La Roche AG; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Protein Assays Market Characteristics

3. Protein Assays Market Trends And Strategies

4. Protein Assays Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Protein Assays Market Size and Growth

• 5.1. Global Protein Assays Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Protein Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Protein Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Protein Assays Market Segmentation

• 6.1. Global Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Reagents And Kits
• Instruments
• 6.2. Global Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Absorbance Based Protein Assays
• Colorimetric Protein Assays
• Fluorescence Based Protein Assays
• 6.3. Global Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical Industry
• Biotechnology Industry
• Clinical Laboratories
• Hospitals
• Academic Research Institutes

7. Protein Assays Market Regional And Country Analysis

• 7.1. Global Protein Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Protein Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Protein Assays Market

• 8.1. Asia-Pacific Protein Assays Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Protein Assays Market

• 9.1. China Protein Assays Market Overview
• 9.2. China Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Protein Assays Market

• 10.1. India Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Protein Assays Market

• 11.1. Japan Protein Assays Market Overview
• 11.2. Japan Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Protein Assays Market

• 12.1. Australia Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Protein Assays Market

• 13.1. Indonesia Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Protein Assays Market

• 14.1. South Korea Protein Assays Market Overview
• 14.2. South Korea Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Protein Assays Market

• 15.1. Western Europe Protein Assays Market Overview
• 15.2. Western Europe Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Protein Assays Market

• 16.1. UK Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Protein Assays Market

• 17.1. Germany Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Protein Assays Market

• 18.1. France Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Protein Assays Market

• 19.1. Italy Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Protein Assays Market

• 20.1. Spain Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Protein Assays Market

• 21.1. Eastern Europe Protein Assays Market Overview
• 21.2. Eastern Europe Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Protein Assays Market

• 22.1. Russia Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Protein Assays Market

• 23.1. North America Protein Assays Market Overview
• 23.2. North America Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Protein Assays Market

• 24.1. USA Protein Assays Market Overview
• 24.2. USA Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Protein Assays Market

• 25.1. Canada Protein Assays Market Overview
• 25.2. Canada Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Protein Assays Market

• 26.1. South America Protein Assays Market Overview
• 26.2. South America Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Protein Assays Market

• 27.1. Brazil Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Protein Assays Market

• 28.1. Middle East Protein Assays Market Overview
• 28.2. Middle East Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Protein Assays Market

• 29.1. Africa Protein Assays Market Overview
• 29.2. Africa Protein Assays Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Protein Assays Market, Segmentation By Technology Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Protein Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Protein Assays Market Competitive Landscape And Company Profiles

• 30.1. Protein Assays Market Competitive Landscape
• 30.2. Protein Assays Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. General Electric Company
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. F. Hoffmann-La Roche AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. AstraZeneca plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Protein Assays Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Roche Diagnostics International AG
• 31.3. Takeda Pharmaceutical Company Limited
• 31.4. Danaher Corporation
• 31.5. Eli Lilly and Company
• 31.6. Merck KGaA
• 31.7. Siemens Healthineers AG
• 31.8. R&D Systems Inc.
• 31.9. Lonza Group AG
• 31.10. PerkinElmer Inc.
• 31.11. Bio-Rad Laboratories Inc.
• 31.12. Takara Bio Inc.
• 31.13. Qiagen N.V.
• 31.14. Promega Corporation
• 31.15. Abcam plc

32. Global Protein Assays Market Competitive Benchmarking

33. Global Protein Assays Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Protein Assays Market

35. Protein Assays Market Future Outlook and Potential Analysis

• 35.1 Protein Assays Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Protein Assays Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Protein Assays Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer